BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1818799)

  • 21. KB cells for antinuclear antibody determination: comparison with HEp-2 cells and the Crithidia luciliae assay.
    Keil LB; DeBari VA; Needle MA
    Diagn Immunol; 1984; 2(4):213-8. PubMed ID: 6396019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using the antinuclear antibody test to diagnose rheumatic diseases: when does a positive test warrant further investigation?
    Volkmann ER; Taylor M; Ben-Artzi A
    South Med J; 2012 Feb; 105(2):100-4. PubMed ID: 22267099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Evaluation of ELISA and Chemiluminescent Assays as Alternative Screening Tests to Indirect Immunofluorescence for the Detection of Antibodies to Cellular Antigens.
    de Almeida Brito F; Maria Elói Santos S; Aparecida Ferreira G; Pedrosa W; Gradisse J; Cristina Costa L; Pretti Figueiredo Neves S
    Am J Clin Pathol; 2016 Mar; 145(3):323-31. PubMed ID: 27124914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the methods used for the detection of antinuclear antibodies].
    Berkem R; Gümüş T; Karakoç E; Acar N
    Mikrobiyol Bul; 2003; 37(2-3):171-8. PubMed ID: 14593900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Problems in ANA test interpretation: a comparison of two substrates.
    Rippey JH; Carter S; Hood P; Carter JB
    Diagn Immunol; 1985; 3(1):43-6. PubMed ID: 3873318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANA detected by ELISA using nucleus of egg cell as antigen.
    Hui L; Shijun L; Yue M
    J Immunoassay Immunochem; 2008; 29(2):161-6. PubMed ID: 18360811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
    Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
    J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of antinuclear antibodies: assessment of different test systems.
    Kern P; Kron M; Hiesche K
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):72-8. PubMed ID: 10618281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of anti-nuclear antibody by immunofluorescence assay and enzyme immunoassay in childhood systemic lupus erythematosus: experience from Bangladesh.
    Dipti TR; Azam MS; Sattar MH; Rahman SA
    Int J Rheum Dis; 2012 Feb; 15(1):121-5. PubMed ID: 22324956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinuclear antibodies (ANA) screening by enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: analytical and clinical evaluation.
    González C; Guevara P; Alarcón I; Hernando M; Navajo JA; González-Buitrago JM
    Clin Biochem; 2002 Sep; 35(6):463-9. PubMed ID: 12413607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cold reacting antinuclear antibody in Henoch-Schönlein Purpura.
    Saulsbury FT; Pearl ER
    J Clin Lab Immunol; 1983 Nov; 12(3):123-7. PubMed ID: 6363709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.
    Mahler M; Hanly JG; Fritzler MJ
    Autoimmun Rev; 2012 Jul; 11(9):642-5. PubMed ID: 22100330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A bag of cells approach for antinuclear antibodies HEp-2 image classification.
    Wiliem A; Hobson P; Minchin RF; Lovell BC
    Cytometry A; 2015 Jun; 87(6):549-57. PubMed ID: 25492545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New genetically engineered DFS70 knock-out HEp-2 cells enable rapid and specific recognition of anti-DFS70 antibodies.
    Bizzaro N; Fabris M
    Autoimmunity; 2018 Jun; 51(4):152-156. PubMed ID: 29732925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application of a human immortalized fibroblast cell line in laboratory diagnosis of autoimmune diseases].
    Chiang LC; Chiang W; Wu CH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 May; 10(5):244-9. PubMed ID: 8040927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of anti-nuclear antibodies from patients with systemic rheumatic diseases by ELISA using HEp-2 cell nuclei.
    Jitsukawa T; Nakajima S; Usui J; Watanabe H
    J Clin Lab Anal; 1991; 5(1):49-53. PubMed ID: 1999763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of circulating anticellular antibodies by indirect immunofluorescence on HEp-2 cell substrates: study of the clinical value of rare fluorescence patterns].
    Haberhauer G; Bröll H
    Z Gesamte Inn Med; 1988 Jul; 43(14):377-80. PubMed ID: 3064447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral lichenoid lesions and serum antinuclear antibodies in Thai patients.
    Prucktrakul C; Youngnak-Piboonratanakit P; Kanjanabuch P; Prueksrisakul T; Thongprasom K
    J Oral Pathol Med; 2015 Jul; 44(6):468-74. PubMed ID: 25213373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity.
    Molden DP; Nakamura RM; Tan EM
    Am J Clin Pathol; 1984 Jul; 82(1):57-66. PubMed ID: 6377871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antinuclear antibodies in diagnosis of rheumatic diseases (author's transl)].
    Helmke K; Scheuermann R; Boeder T; Oppermann M; Teuber J; Federlin K
    Klin Wochenschr; 1981 Mar; 59(6):287-96. PubMed ID: 7015004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.